Wolfe Research analyst Alexandria Hammond initiated coverage of Moderna (MRNA) with an Underperform rating and $40 price target Moderna may ...

Wolfe Research initiated coverage of BioMarin (BMRN) with an Outperform rating and $95 price target With limited downside risk following ...

Fintel reports that on November 14, 2024, Wolfe Research initiated coverage of Maravai LifeSciences Holdings (NasdaqGS:MRVI) ...

Earlier, on September 5, 2024, Wolfe Research had resumed the stock to Underperform, setting a price target of $1. William Blair also initiated Mkt Perform rating. Additionally, Wolfe Research reduced ...

On Wednesday, RLJ Lodging Trust (RLJ) stock saw a modest uptick, ending the day at $10.01 which represents a slight increase of $0.07 or 0.70% from the prior close of $9.94. The stock opened at $9.96 ...

Fintel reports that on November 13, 2024, Wolfe Research upgraded their outlook for Phillips Edison (NasdaqGS:PECO) from Peer ...

Voters really don't like inflation. In fact, whenever there's a sustained jump in the cost of living, the party in power ...

Wolfe Research upgrades Warner Bros. Discovery to peer perform, citing potential for stable EBITDA and debt reduction through ...

Investing.com - Wolfe Research has upgraded shares of Warner Bros. Discovery (NASDAQ: NASDAQ: WBD) to Peer Perform from ...

From bringing out the child within to adding sweetness amidst a dark time, Chef Christina Tosi continues to wield her sweet ...

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to ...